SCHEMBL885974

SCHEMBL885974

O=C(O)N1CCN(C(=O)c2[nH]c(=O)n(-c3ccccc3)c2-c2ccccc2Cl)CC1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.40
HTT P42858 1/20 0.40
ALDH1A1 P00352 6/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
HSD17B10 Q99714 2/20 0.39
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
ALOX5 P09917 1/20 0.39
PTGS2 P35354 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
TSHR P16473 1/20 0.38
RAB9A P51151 3/20 0.37
SMO Q99835 1/20 0.37
NPC1 O15118 2/20 0.37
USP2 O75604 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
HSP90AA1 P07900 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2063135 0.90 RXFP1 (0.49) LMNAALDH1A1MEN1KMT2AHSD17B10
SCHEMBL10224522 0.85 CNR1 (0.45) MEN1KMT2AHSD17B10TSHR
SCHEMBL2063853 0.84 ALDH1A1 (0.42) LMNAALDH1A1MEN1KMT2AHSD17B10
SCHEMBL885673 0.84 ALOX5 (0.43) LMNAALDH1A1MEN1KMT2AHSD17B10
SCHEMBL885816 0.82 KMT2A (0.46) LMNAALDH1A1MEN1KMT2AHSD17B10
SCHEMBL885971 0.82 ALDH1A1 (0.47) LMNAHTTALDH1A1MEN1KMT2A
SCHEMBL886152 0.77 MAT2A (0.48) LMNAALDH1A1HSD17B10GAAHPGD
SCHEMBL885738 0.75 ALDH1A1 (0.41) LMNAALDH1A1MEN1KMT2AHSD17B10
SCHEMBL2062757 0.74 SCN5A (0.46) LMNAHTTALDH1A1KMT2AHSD17B10
SCHEMBL2063138 0.73 SIGMAR1 (0.49) LMNAALDH1A1MEN1KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008089005-A2 RENIN INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-07-24 WO claimed
US-8148367-B2 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-04-03 US disclosed
US-20100105665-A1 RENIN INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-04-29 US disclosed
WO-2008089005-A2 RENIN INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-07-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100105665-A1 RENIN INHIBITORS REN, ACE, AGT LMNA 824/4885HTT 3604/4885ALDH1A1 947/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.